These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

348 related articles for article (PubMed ID: 11906173)

  • 1. Attenuation of transforming growth factor beta-induced growth inhibition in human hepatocellular carcinoma cell lines by cyclin D1 overexpression.
    Jong HS; Lee HS; Kim TY; Im YH; Park JW; Kim NK; Bang YJ
    Biochem Biophys Res Commun; 2002 Mar; 292(2):383-9. PubMed ID: 11906173
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Overexpression of transforming growth factor (TGF) beta1 type II receptor restores TGF-beta1 sensitivity and signaling in human prostate cancer cells.
    Guo Y; Kyprianou N
    Cell Growth Differ; 1998 Feb; 9(2):185-93. PubMed ID: 9486855
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Involvement of interferon regulatory factor 1 and S100C/A11 in growth inhibition by transforming growth factor beta 1 in human hepatocellular carcinoma cells.
    Miyazaki M; Sakaguchi M; Akiyama I; Sakaguchi Y; Nagamori S; Huh NH
    Cancer Res; 2004 Jun; 64(12):4155-61. PubMed ID: 15205326
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Growth inhibition of human hepatoma cells by acyclic retinoid is associated with induction of p21(CIP1) and inhibition of expression of cyclin D1.
    Suzui M; Masuda M; Lim JT; Albanese C; Pestell RG; Weinstein IB
    Cancer Res; 2002 Jul; 62(14):3997-4006. PubMed ID: 12124333
    [TBL] [Abstract][Full Text] [Related]  

  • 5. TGF-beta1-induced cell growth arrest and partial differentiation is related to the suppression of Id1 in human hepatoma cells.
    Damdinsuren B; Nagano H; Kondo M; Natsag J; Hanada H; Nakamura M; Wada H; Kato H; Marubashi S; Miyamoto A; Takeda Y; Umeshita K; Dono K; Monden M
    Oncol Rep; 2006 Feb; 15(2):401-8. PubMed ID: 16391861
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Amplification and overexpression of cyclin D1 in human hepatocellular carcinoma.
    Zhang YJ; Jiang W; Chen CJ; Lee CS; Kahn SM; Santella RM; Weinstein IB
    Biochem Biophys Res Commun; 1993 Oct; 196(2):1010-6. PubMed ID: 8240318
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Transforming growth factor beta 1 can induce CIP1/WAF1 expression independent of the p53 pathway in ovarian cancer cells.
    Elbendary A; Berchuck A; Davis P; Havrilesky L; Bast RC; Iglehart JD; Marks JR
    Cell Growth Differ; 1994 Dec; 5(12):1301-7. PubMed ID: 7696178
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Distortion of autocrine transforming growth factor beta signal accelerates malignant potential by enhancing cell growth as well as PAI-1 and VEGF production in human hepatocellular carcinoma cells.
    Sugano Y; Matsuzaki K; Tahashi Y; Furukawa F; Mori S; Yamagata H; Yoshida K; Matsushita M; Nishizawa M; Fujisawa J; Inoue K
    Oncogene; 2003 Apr; 22(15):2309-21. PubMed ID: 12700666
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Menatetrenone, a vitamin K2 analogue, inhibits hepatocellular carcinoma cell growth by suppressing cyclin D1 expression through inhibition of nuclear factor kappaB activation.
    Ozaki I; Zhang H; Mizuta T; Ide Y; Eguchi Y; Yasutake T; Sakamaki T; Pestell RG; Yamamoto K
    Clin Cancer Res; 2007 Apr; 13(7):2236-45. PubMed ID: 17404108
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Transforming growth factor beta 1 (TGF beta 1) is an autocrine positive regulator of colon carcinoma U9 cells in vivo as shown by transfection of a TGF beta 1 antisense expression plasmid.
    Huang F; Newman E; Theodorescu D; Kerbel RS; Friedman E
    Cell Growth Differ; 1995 Dec; 6(12):1635-42. PubMed ID: 9019169
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Functional switching of TGF-beta1 signaling in liver cancer via epigenetic modulation of a single CpG site in TTP promoter.
    Sohn BH; Park IY; Lee JJ; Yang SJ; Jang YJ; Park KC; Kim DJ; Lee DC; Sohn HA; Kim TW; Yoo HS; Choi JY; Bae YS; Yeom YI
    Gastroenterology; 2010 May; 138(5):1898-908. PubMed ID: 20038433
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Leptin induces proliferation and anti-apoptosis in human hepatocarcinoma cells by up-regulating cyclin D1 and down-regulating Bax via a Janus kinase 2-linked pathway.
    Chen C; Chang YC; Liu CL; Liu TP; Chang KJ; Guo IC
    Endocr Relat Cancer; 2007 Jun; 14(2):513-29. PubMed ID: 17639064
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Sensitivity to transforming growth factor beta 1-induced growth arrest is common in human squamous cell carcinoma cell lines: c-MYC down-regulation and p21waf1 induction are important early events.
    Malliri A; Yeudall WA; Nikolic M; Crouch DH; Parkinson EK; Ozanne B
    Cell Growth Differ; 1996 Oct; 7(10):1291-304. PubMed ID: 8891333
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Autocrine stimulatory mechanism by transforming growth factor beta in human hepatocellular carcinoma.
    Matsuzaki K; Date M; Furukawa F; Tahashi Y; Matsushita M; Sakitani K; Yamashiki N; Seki T; Saito H; Nishizawa M; Fujisawa J; Inoue K
    Cancer Res; 2000 Mar; 60(5):1394-402. PubMed ID: 10728705
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Expression of transforming growth factor-beta1 and transforming growth factor-beta receptors in hepatocellular carcinoma and dysplastic nodules.
    Paik SY; Park YN; Kim H; Park C
    Mod Pathol; 2003 Jan; 16(1):86-96. PubMed ID: 12527718
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Involvement of programmed cell death 4 in transforming growth factor-beta1-induced apoptosis in human hepatocellular carcinoma.
    Zhang H; Ozaki I; Mizuta T; Hamajima H; Yasutake T; Eguchi Y; Ideguchi H; Yamamoto K; Matsuhashi S
    Oncogene; 2006 Oct; 25(45):6101-12. PubMed ID: 16682950
    [TBL] [Abstract][Full Text] [Related]  

  • 17. p53 dephosphorylation and p21(Cip1/Waf1) translocation correlate with caspase-3 activation in TGF-beta1-induced apoptosis of HuH-7 cells.
    Fan G; Ma X; Wong PY; Rodrigues CM; Steer CJ
    Apoptosis; 2004 Mar; 9(2):211-21. PubMed ID: 15004518
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Effect of transforming growth factor-beta1 on the cell growth and Epstein-Barr virus reactivation in EBV-infected epithelial cell lines.
    Fukuda M; Ikuta K; Yanagihara K; Tajima M; Kuratsune H; Kurata T; Sairenji T
    Virology; 2001 Sep; 288(1):109-18. PubMed ID: 11543663
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Abrogation of transforming growth factor-beta type II receptor stimulates embryonic mouse lung branching morphogenesis in culture.
    Zhao J; Bu D; Lee M; Slavkin HC; Hall FL; Warburton D
    Dev Biol; 1996 Nov; 180(1):242-57. PubMed ID: 8948588
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Cyclooxygenase-2 induction and transforming growth factor beta growth inhibition in rat intestinal epithelial cells.
    Sheng H; Shao J; Hooton EB; Tsujii M; DuBois RN; Beauchamp RD
    Cell Growth Differ; 1997 Apr; 8(4):463-70. PubMed ID: 9101092
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 18.